Revalor® XS

FOR ANIMAL USE ONLY

REVALOR^®-XS

Reg. No. G3925 (Act 36/1947)

INDICATIONS

Revalor^® XS is used to increase weight gain and improve feed efficiency for up to 200 days when administered once to steers and bulls fed in confinement for slaughter. For use in cattle only.

COMPOSITION

Each implant contains: 200 mg trenbolone acetate and 40 mg 17ß-oestradiol.

STORAGE

• Store unopened product at or below 25 °C.
• Avoid excessive heat and humidity.
• Use product before the expiry date.

WARNINGS

• Withdrawal Period: Meat and offal – Do not slaughter animals for human consumption within 70 days of the pellet being implanted in the ear.
• DO NOT USE IN ANIMALS INTENDED FOR BREEDING PURPOSES, OR IN DAIRY ANIMALS.
• Handle with care. Harmful if swallowed.
• Implant pellets behind ear only. Do not use implant site for human or animal consumption.
• Store away from food and feed.
• Dispose of any containers, disposable equipment and any other waste after use, in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008) and do not reuse for any other purpose.
• KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
• Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

CONTRAINDICATIONS

• Do not use in pregnant animals.
• Do not use in lactating animals.
• Do not use in breeding animals.
• Do not use in calves to be processed for veal.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

A cartridge consists of 10 implants each containing 10 small tablets. A single implant is placed under the skin by means of a special implanter (Refer to implanter instructions).

Site of implantation

After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site.

The site of implantation is the soft skin on the posterior aspect of the ear.

The implant should be placed as far from the head as is possible without inserting the implanter into the area where the skin is firmly attached to the cartilage.

THE IMPLANT MUST NOT BE PLACED CLOSER TO THE HEAD THAN THE EDGE OF THE CARTILAGE RING FARTHEST FROM THE HEAD.

The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site.

Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.